Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nortech SystemsNSYS +1.73%54 10-Year RORE % is 12.79 as of Mar. 2026. GuruFocus rates NSYS with a GF Score™ of 54/100 and a GF Value™ of $9.23 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 426 Medical Devices & Instruments companies, Nortech Systems ranks better than 72.54% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Nortech Systems's 10-Year RORE % for the quarter that ended in Mar. 2026 was 12.79%.
The industry rank for Nortech Systems's 10-Year RORE % or its related term are showing as below:
NSYS's 10-Year RORE % is ranked better than 72.54% of 426
companies
in the Medical Devices & Instruments industry
Industry Median: 1.07
vs NSYS: 12.79
Nortech Systems (NAS:NSYS) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Nortech Systems 10-Year RORE % Related Terms
Nortech Systems 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for Nortech Systems's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSYS vs ELUT, SRTS, MYO: 10-Year RORE % Comparison
For the Medical Devices subindustry, Nortech Systems's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nortech Systems 10-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nortech Systems's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Nortech Systems's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.
Nortech Systems (NSYS) has a 10-Year RORE % of 12.79 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Nortech Systems and its competitors. According to the industry distribution chart, Nortech Systems ranks #117 out of 426 companies in the Medical Devices & Instruments industry, placing it in the top 27.5%.
Is Nortech Systems' 10-Year RORE % too high?
Nortech Systems' current 10-Year RORE % is 12.79. The Medical Devices & Instruments industry median 10-Year RORE % is 1.07. Nortech Systems' value of 12.79 is 1095.3% above this industry median. Based on the distribution chart, Nortech Systems ranks #117 out of 426 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nortech Systems has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nortech Systems' 10-Year RORE % compare to ELUT and SRTS?
According to the Medical Devices & Instruments industry distribution chart, Nortech Systems ranks #117 out of 426 companies for 10-Year RORE %. This puts Nortech Systems in the upper half of its industry. The industry median 10-Year RORE % is 1.07. Nortech Systems' value of 12.79 is 1095.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Medical Devices & Instruments company?
The median 10-Year RORE % among Medical Devices & Instruments companies is 1.07, based on 426 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nortech Systems's current 10-Year RORE % of 12.79 is 1095.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Nortech Systems and its competitors. For the Medical Devices & Instruments industry, the median 10-Year RORE % is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nortech Systems's current 10-Year RORE % is 12.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nortech Systems stock overvalued right now?
Based on GuruFocus' analysis, Nortech Systems (NSYS) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.23, compared to a current price of $14.14 — trading 53.2% above its estimated fair value. The current 10-Year RORE % is 12.79 and 1095.3% above the Medical Devices & Instruments industry median of 1.07. Nortech Systems' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Nortech Systems (NSYS), the current 10-Year RORE % is 12.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nortech Systems (NSYS) Overvalued in 2026?
Based on GuruFocus' analysis, Nortech Systems stock appears to be overvalued.
The current stock price of $14.14 is trading 53.2% above its estimated GF Value™ of $9.23.
GuruFocus considers Nortech Systems to be Significantly Overvalued.
Key valuation signals for NSYS:
10-Year RORE %: 12.79
GF Value™: $9.23 vs. price of $14.14 (53.2% above fair value)
Industry Position: 1095.3% above the Medical Devices & Instruments median (#117 of 426)
No single metric tells the full story. See the NSYS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
54GF Score
Get the complete analysis for NSYS
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSYS has been successfully added to your 
